Health Care & Life Sciences » Biotechnology | Global Blood Therapeutics Inc.

Global Blood Therapeutics Inc. | Ownership

Companies that own Global Blood Therapeutics Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Fidelity Management & Research Co.
4,895,014
9.4%
-1,530,965
0.02%
06/30/2018
Perceptive Advisors LLC
4,828,910
9.27%
-160,156
5.39%
06/30/2018
Henderson Global Investors Ltd.
4,154,385
7.98%
452,843
0.09%
06/30/2018
Wellington Management Co. LLP
4,016,423
7.72%
-324,768
0.04%
06/30/2018
The Vanguard Group, Inc.
3,993,471
7.67%
207,100
0.01%
06/30/2018
BlackRock Fund Advisors
3,617,288
6.95%
746,399
0.01%
06/30/2018
T. Rowe Price Associates, Inc.
2,747,597
5.28%
214,308
0.02%
06/30/2018
SSgA Funds Management, Inc.
2,420,163
4.65%
373,768
0.01%
06/30/2018
Camber Capital Management LLC
2,200,000
4.23%
1,000,000
4.38%
06/30/2018
FIAM LLC
1,529,632
2.94%
762,034
0.15%
06/30/2018

About Global Blood Therapeutics

View Profile
Address
171 Oyster Point Boulevard
South San Francisco California 94080
United States
Employees -
Website http://www.gbt.com
Updated 07/08/2019
Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.